A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects
Status:
COMPLETED
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study including Part A single ascending dose (SAD) in healthy subjects and Part B single dose in subjects with mild hypertension.